PRPO
Precipio IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$55.22M
P/E Ratio
—
EPS
$-0.23
Beta
1.20
52W High
$32.40
52W Low
$5.94
50-Day MA
$27.11
200-Day MA
$21.87
Dividend Yield
—
Profit Margin
-1.51%
Forward P/E
15.43
PEG Ratio
0.00
About Precipio Inc
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | $24.05M |
| Gross Profit (TTM) | $10.71M |
| EBITDA | 231,000 |
| Operating Margin | 8.09% |
| Return on Equity | -2.72% |
| Return on Assets | -3.92% |
| Revenue/Share (TTM) | $14.98 |
| Book Value | $8.18 |
| Price-to-Book | 3.82 |
| Price-to-Sales (TTM) | 2.30 |
| EV/Revenue | 2.357 |
| EV/EBITDA | 38.77 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.90% |
| Shares Outstanding | $1.78M |
| Float | $1.45M |
| % Insiders | 11.94% |
| % Institutions | 17.18% |
Historical Volatility
HV 10-Day
81.37%
HV 20-Day
67.92%
HV 30-Day
68.42%
HV 60-Day
69.68%
HV Rank
38.9%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/2/2026